author-photo

A. de Gramont

University of Paris

242

Papers

10686

Citations

Citation Trend

Filter By

Papers (167) Sort By

Journal Conference Others

O-9 5-FU/LV + cetuximab + vemurafenib as maintenance therapy for BRAF-mutant (BRAFmut) metastatic colorectal cancer: Efficacy, safety, and exploratory biomarker findings from Cohort 1 of the MODUL trial

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
59TiP Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
80TiP Global phase III study of NUC-1031 plus cisplatin vs gemcitabine plus cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Evaluation of the Change of Outcomes over a Ten-Year Period in Patients with Stage III Colon Cancer: Pooled Analysis of 6501 Patients Treated with Fluorouracil, Leucovorin, and Oxaliplatin in the ACCENT Database

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (13)
434P Impact of molecular markers status on treatment effects comparing EGFR and VEGF monoclonal antibodies (mAbs) in untreated metastatic colorectal cancer (mCRC): Pooled individual patient data (IPD) analysis of randomized trials from the ARCAD database

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (2)
LBA30_PRAnalysis of circulating tumour DNA (ctDNA) from patients enrolled in the IDEA-FRANCE phase III trial: Prognostic and predictive value for adjuvant treatment duration

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (26)
553PBevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (CC): Updated analysis of stage II disease from the AVANT phase III randomized trial by the GERCOR group

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an accent pooled analysis of 7 studies

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (49)
LBA19Fluoropyrimidine (FP) + bevacizumab (BEV) + atezolizumab vs FP/BEV in BRAFwt metastatic colorectal cancer (mCRC): Findings from Cohort 2 of MODUL – a multicentre, randomized trial of biomarker-driven maintenance treatment following first-line induction therapy

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (49)
Low-level postoperative carcinoembryonic antigen improves survival outcomes stratification in patients with stage II colon cancer treated with standard adjuvant treatments

2018 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (6)